Danaher Corporation a leading global life sciences and diagnostics innovator, announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025.
Mr. Milosevich has served as Vice President and Group Executive of the Life Sciences Innovations Group since 2021. With this expanded role, he will become an executive officer of Danaher and will continue reporting to Rainer Blair, President and Chief Executive Officer.
"Greg has played a pivotal role in advancing our Life Sciences Innovations Group over the past four years," said Rainer Blair. "His consistent ability to deliver results, deep customer focus and talent for building high-performing teams—combined with his strong embodiment of the Danaher Business System—make him an outstanding leader. I'm confident he will continue to drive success as he takes on this expanded role."
Comments powered by CComment